Showing results (41-50 of 80) with videos related to
Sort By:
Pageof 8
JACC. Cardiovascular Interventions|May 29, 2018
Long-Term Coronary Functional Assessment of the Infarct-Related Artery Treated With Everolimus-Eluting Bioresorbable Scaffolds or Everolimus-Eluting Metallic Stents: Insights of the TROFI II TrialJosep Gomez-Lara, Salvatore Brugaletta, Luis Ortega-Paz, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 2, 2011
Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trialSalvatore Brugaletta, Josep Gomez-Lara, Nico Bruining, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 19, 2011
CRosser As First choice for crossing Totally occluded coronary arteries (CRAFT Registry): focus on conventional angiography and computed tomography angiography predictors of successHéctor M García-García, Salvatore Brugaletta, Carlos A G van Mieghem, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 28, 2022
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trialLuis Ortega-Paz, Salvatore Brugaletta, Josep Gomez-Lara, et al.Circulation|September 26, 2019
Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical TrialManel Sabaté, Fernando Alfonso, Angel Cequier, et al.The Journal of Invasive Cardiology|September 8, 2022
Real-World Multicenter Coronary Lithotripsy Registry: Long-Term Clinical Follow-UpHector Cubero-Gallego, Alicia Calvo-Fernandez, Helena Tizon-Marcos, et al.The Journal of Invasive Cardiology|December 4, 2013
Global risk score for choosing the best revascularization strategy in patients with unprotected left main stenosisJosep Gomez-Lara, Gerard Roura, Arnau Blasco-Lucas, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 2, 2021
First-in-Man Evaluation of a Sirolimus-Eluting Stent With Abluminal Fluoropolymeric/Triflusal Coating With Ultrathin Struts by OCT at 9 Months' Follow-Up: The PROMETHEUS StudyJose M de la Torre Hernandez, Imanol Otaegui, Asier Subinas, et al.American Heart Journal|August 29, 2018
Ticagrelor versus clopidogrel for recovery of vascular function immediately after successful chronic coronary total occlusion recanalization: A randomized clinical trialSalvatore Brugaletta, Josep Gomez-Lara, Juan Caballero, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 28, 2011
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-studyJosep Gomez-Lara, Roberto Diletti, Salvatore Brugaletta, et al.Pageof 8